$TSOI To whom in may concern: ARDS/Lung injury caused by Covid-19 has resulted in a countless loss of life. A Biotech Firm out of Oceanside, CA has developed a UC-MSC Therapy that achieved 91% efficacy in its Phase 1/2a trial in 2020. That therapy is now available via Right To Try. Please share the attached information with all concerned parties. Sincerely, A Concerned Citizen “Therapeutic Solutions International, Inc. has announced the preparation for filing an Emergency Use Authorization (EUA) to the FDA for JadiCells™ in treatment of COVID-19 associated lung injury. If you are a Physician or Hospital Administrator interested in obtaining JadiCells™ in treatment of COVID-19 lung failure under EUA, eIND, or Right to Try, please use the email contact for James Veltmeyer, M.D., Chief Medical Officer of the company at firstname.lastname@example.org” therapeuticsolutionsint.com... stemcellsjournals.onlinelib...